Tag: BYD Korea
Top News
Navigating FDA Challenges: How SK Biopharmaceuticals Plans to Move Forward with...
SK Biopharm will maintain its development and commercialization plans for epilepsy drug candidate Opacalim despite FDA's partial clinical hold.
- Our Sponsors Ad -